The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy
International Journal of Oncology · 2023
DOI: 10.3892/ijo.2023.5503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Xiya Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China. Hauptthemen laut MEDLINE: Neovascularization, Pathologic, Photochemotherapy, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Zitieren
APA
Guo, X., Niu, Y., Han, W., Han, X., Chen, Q., Tian, S., Zhu, Y., Bai, D., & Li, K. (2023). The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5503
Vancouver
Guo X, Niu Y, Han W, Han X, Chen Q, Tian S, et al. The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5503
BibTeX
@article{Guo2023,
author = {Guo, Xiya and Niu, Yajuan and Han, Wang and Han, Xiaoyu and Chen, Qing and Tian, Si and Zhu, Ying and Bai, Dingqun and Li, Kaiting},
title = {The ALK1‑Smad1/5‑ID1 pathway participates in tumour angiogenesis induced by low‑dose photodynamic therapy},
journal = {International Journal of Oncology},
year = {2023},
doi = {10.3892/ijo.2023.5503}
}
EUVIMED